Embecta Corp.(EMBC)Earnings, Financials & Key Ratios

EMBC•NASDAQ

$3.56

$211M mkt cap·2.2× P/E·Price updated May 6, 2026

SectorHealthcare IndustrySpecialty & Generic Pharma Sub-IndustryConsumer health and OTC self-care

AboutEmbecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.Show more

Revenue$1.08B-3.8%
EBITDA$380M+75.5%
Net Income$95M+21.8%
EPS (Diluted)1.62+20.9%
Gross Margin62.89%-3.1%
EBITDA Margin35.21%+82.5%
Operating Margin30.48%+96.5%
Net Margin8.83%+26.7%
ROIC42.7%+78.6%
Interest Coverage2.27+62.9%

Technical→

EMBC Key Insights

Embecta Corp. (EMBC) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓FCF machine: 16.9% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Healthy 5Y average net margin of 15.5%

✗Weaknesses

✗Profits declining 25.9% over 5 years
✗Weak momentum: RS Rating 17 (bottom 17%)
✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

EMBC Price & Volume

Embecta Corp. (EMBC) stock price & volume — 10-year historical chart

Loading chart...

EMBC Growth Metrics

Embecta Corp. (EMBC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years-0.09%

3 Years-1.47%

TTM-3.43%

Profit CAGR

10 Years-

5 Years-25.92%

3 Years-24.72%

TTM114.78%

EPS CAGR

10 Years-

5 Years-26.4%

3 Years-25.32%

TTM37.37%

Return on Capital

10 Years54.33%

5 Years43.87%

3 Years28.46%

Last Year37.84%

EMBC Recent Earnings

Embecta Corp. (EMBC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 10/12 qtrs (83%)●Beat Revenue 8/12 qtrs (67%)

Q2 2026Latest

May 5, 2026

EPS

$0.27

Est $0.42

-35.7%

Revenue

$222M

Est $232M

-4.6%

Q1 2026

Feb 5, 2026

EPS

$0.71

Est $0.67

+6.0%

Revenue

$261M

Est $258M

+1.2%

Q4 2025

Nov 25, 2025

EPS

$0.50

Est $0.70

-28.6%

Revenue

$264M

Est $258M

+2.2%

Q3 2025

Aug 8, 2025

EPS

$1.12

Est $0.46

+146.2%

Revenue

$296M

Est $266M

+11.2%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	May 5, 2026	$0.27vs $0.42-35.7%	$222Mvs $232M-4.6%
Q1 2026	Feb 5, 2026	$0.71vs $0.67+6.0%	$261Mvs $258M+1.2%
Q4 2025	Nov 25, 2025	$0.50vs $0.70-28.6%	$264Mvs $258M+2.2%
Q3 2025	Aug 8, 2025	$1.12vs $0.46+146.2%	$296Mvs $266M+11.2%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
UTMDUtah Medical Products, Inc.Direct Competitor	206.35M	64.41	18.51	-5.83%	29.3%	9.56%	0.00
LFUSLittelfuse, Inc.Direct Competitor	11.11B	441.67	-152.30	8.92%	-1.61%	-1.57%	0.39
NVCRNovoCure LimitedDirect Competitor	1.88B	16.50	-13.52	8.28%	-25.66%	-50.82%	0.85
ITGRInteger Holdings CorporationDirect Competitor	2.97B	86.29	29.86	7.57%	7.67%	8.23%	0.80
MMSIMerit Medical Systems, Inc.Direct Competitor	3.68B	61.63	28.93	11.66%	9.03%	8.95%	0.57
BDXBecton, Dickinson and CompanyProduct Competitor	52.45B	144.76	24.83	8.23%	8.01%	6.93%	0.76
NVONovo Nordisk A/SProduct Competitor	203.36B	45.76	12.65	6.43%	33.14%	61.1%	0.67
DXCMDexCom, Inc.Product Competitor	23.29B	60.36	28.88	15.6%	19.31%	33.83%	0.51

Compare EMBC vs Peers

Embecta Corp. (EMBC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs UTMD

Most directly comparable listed peer for EMBC.

Scale Benchmark

vs LLY

Larger-name benchmark to compare EMBC against a more recognizable public peer.

Peer Set

Compare Top 5

vs UTMD, LFUS, NVCR, ITGR

EMBC Income Statement

Embecta Corp. (EMBC) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Sep'19	Sep'20	Sep'21	Sep'22	Sep'23	Sep'24	Sep'25	TTM
Sales/Revenue	1.11B	1.09B	1.17B	1.13B	1.12B	1.12B	1.08B	1.04B
Revenue Growth %	-	-2.12%	7.32%	-3.05%	-0.77%	0.21%	-3.8%	-3.43%
Cost of Goods Sold	323M	323M	365M	354.6M	370.9M	394.2M	400.9M	402M
COGS % of Revenue	29.13%	29.76%	31.33%	31.39%	33.09%	35.1%	37.11%	-
Gross Profit	786M▲ 0%	763M▼ 2.9%	800M▲ 4.8%	774.9M▼ 3.1%	749.9M▼ 3.2%	728.9M▼ 2.8%	679.5M▼ 6.8%	640.5M▲ 0%
Gross Margin %	70.87%	70.29%	68.67%	68.61%	66.91%	64.9%	62.89%	61.44%
Gross Profit Growth %	-	-2.93%	4.85%	-3.14%	-3.23%	-2.8%	-6.78%	-
Operating Expenses	284M	276M	308M	396.8M	520.3M	554.7M	350.2M	351.7M
OpEx % of Revenue	25.61%	25.43%	26.44%	35.13%	46.42%	49.39%	32.41%	-
Selling, General & Admin	222M	215M	240M	294.8M	341.3M	365.1M	331.4M	325.1M
SG&A % of Revenue	20.02%	19.81%	20.6%	26.1%	30.45%	32.51%	30.67%	-
Research & Development	62M	61M	63M	65M	85.2M	78.8M	21.5M	18.4M
R&D % of Revenue	5.59%	5.62%	5.41%	5.75%	7.6%	7.02%	1.99%	-
Other Operating Expenses	0	0	5M	37M	93.8M	110.8M	-2.7M	2.4M
Operating Income	502M▲ 0%	487M▼ 3.0%	492M▲ 1.0%	378.1M▼ 23.2%	229.6M▼ 39.3%	174.2M▼ 24.1%	329.3M▲ 89.0%	288.8M▲ 0%
Operating Margin %	45.27%	44.86%	42.23%	33.48%	20.49%	15.51%	30.48%	27.7%
Operating Income Growth %	-	-2.99%	1.03%	-23.15%	-39.28%	-24.13%	89.04%	-
EBITDA	538M	525M	530M	409.8M	262.3M	216.7M	380.4M	316.3M
EBITDA Margin %	48.51%	48.36%	45.49%	36.28%	23.4%	19.29%	35.21%	30.34%
EBITDA Growth %	-	-2.42%	0.95%	-22.68%	-35.99%	-17.38%	75.54%	8.47%
D&A (Non-Cash Add-back)	36M	38M	38M	31.7M	32.7M	42.5M	51.1M	27.5M
EBIT	500M	486M	495M	302.8M	212.7M	156.5M	243.6M	236.9M
Net Interest Income	0	0	0	-46.2M	-107M	-112.3M	-107.3M	-76.8M
Interest Income	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	46.2M	107M	112.3M	107.3M	6M
Other Income/Expense	-2M	-1M	3M	-121.5M	-123.9M	-130M	-193M	-107.5M
Pretax Income	500M▲ 0%	485.8M▼ 2.8%	495M▲ 1.9%	256.6M▼ 48.2%	105.7M▼ 58.8%	44.2M▼ 58.2%	136.3M▲ 208.4%	169.6M▲ 0%
Pretax Margin %	45.09%	44.75%	42.49%	22.72%	9.43%	3.94%	12.62%	16.27%
Income Tax	68M	58.2M	80M	33M	35.3M	-34.1M	40.9M	57.7M
Effective Tax Rate %	13.6%	11.98%	16.16%	12.86%	33.4%	-77.15%	30.01%	34.02%
Net Income	432M▲ 0%	427.6M▼ 1.0%	414.8M▼ 3.0%	223.6M▼ 46.1%	70.4M▼ 68.5%	78.3M▲ 11.2%	95.4M▲ 21.8%	111.9M▲ 0%
Net Margin %	38.95%	39.39%	35.61%	19.8%	6.28%	6.97%	8.83%	10.73%
Net Income Growth %	-	-1.02%	-2.99%	-46.09%	-68.52%	11.22%	21.84%	114.78%
Net Income (Continuing)	432M	427.6M	415M	223.6M	70.4M	78.3M	95.4M	116M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0
EPS (Diluted)	7.58▲ 0%	7.50▼ 1.1%	7.31▼ 2.5%	3.89▼ 46.8%	1.22▼ 68.6%	1.34▲ 9.8%	1.62▲ 20.9%	1.90▲ 0%
EPS Growth %	-	-1.06%	-2.53%	-46.79%	-68.64%	9.84%	20.9%	37.37%
EPS (Basic)	7.58	7.50	7.31	3.92	1.23	1.36	1.64	-
Diluted Shares Outstanding	57M	57M	56.8M	57.06M	57.76M	58.33M	58.91M	58.91M
Basic Shares Outstanding	57M	57M	56.8M	57.06M	57.24M	58.43M	58.31M	58.31M
Dividend Payout Ratio	-	-	-	3.85%	48.86%	44.06%	36.69%	-

EMBC Balance Sheet

Embecta Corp. (EMBC) balance sheet — assets, liabilities & shareholders' equity

Line item	Sep'19	Sep'20	Sep'21	Sep'22	Sep'23	Sep'24	Sep'25	TTM
Total Current Assets	248M	235M	292M	664.7M	749.1M	761M	631.4M	608.1M
Cash & Short-Term Investments	0	0	0	330.9M	326.5M	267.5M	225.5M	184.9M
Cash Only	0	0	0	330.9M	326.3M	267.5M	225.5M	184.9M
Short-Term Investments	0	0	0	0	0	0	0	0
Accounts Receivable	127M	120M	150.6M	23.4M	17.9M	248M	148.9M	147.1M
Days Sales Outstanding	41.8	40.35	47.18	7.56	5.83	80.6	50.3	55.84
Inventory	101M	102M	118M	122.8M	152.1M	171.5M	178.6M	192.6M
Days Inventory Outstanding	114.13	115.26	118	126.4	149.68	158.8	162.61	168.63
Other Current Assets	0	0	200K	109.7M	142.4M	74M	3.1M	83.5M
Total Non-Current Assets	497M	503M	496M	421.7M	465.3M	524.3M	459.5M	421.2M
Property, Plant & Equipment	457M	462M	451M	301.6M	323.2M	290.4M	48.5M	237.5M
Fixed Asset Turnover	2.43x	2.35x	2.58x	3.75x	3.47x	3.87x	22.28x	4.14x
Goodwill	16M	16M	16M	15.7M	15.6M	15.6M	15.4M	21.9M
Intangible Assets	16M	14M	18M	8.9M	9.1M	8.1M	7M	0
Long-Term Investments	0	0	-11.4M	-95.5M	0	0	0	0
Other Non-Current Assets	8M	11M	11M	95.5M	117.4M	210.2M	368.4M	0
Total Assets	745M▲ 0%	738M▼ 0.9%	788M▲ 6.8%	1.09B▲ 37.9%	1.21B▲ 11.8%	1.29B▲ 5.8%	1.09B▼ 15.1%	1.03B▲ 0%
Asset Turnover	1.49x	1.47x	1.48x	1.04x	0.92x	0.87x	0.99x	0.96x
Asset Growth %	-	-0.94%	6.78%	37.87%	11.78%	5.84%	-15.12%	-39.4%
Total Current Liabilities	126M	137M	164M	301M	353.5M	374M	261.5M	247.3M
Accounts Payable	47M	50M	54.2M	41.4M	53.5M	91M	74.2M	79.7M
Days Payables Outstanding	53.11	56.5	54.2	42.61	52.65	84.26	67.56	65.35
Short-Term Debt	0	1M	0	9.5M	9.5M	9.5M	12.9M	13M
Deferred Revenue (Current)	0	-1M	0	0	33.6M	0	0	0
Other Current Liabilities	0	1M	1.1M	198M	33.6M	0	115.2M	154.6M
Current Ratio	1.97x	1.72x	1.78x	2.21x	2.12x	2.03x	2.41x	2.41x
Quick Ratio	1.17x	0.97x	1.06x	1.80x	1.69x	1.58x	1.73x	1.73x
Cash Conversion Cycle	102.82	99.11	110.98	91.35	102.86	155.14	145.36	159.12
Total Non-Current Liabilities	0	29M	29.7M	1.68B	1.68B	1.65B	1.48B	1.41B
Long-Term Debt	0	0	0	1.6B	1.59B	1.57B	1.39B	1.34B
Capital Lease Obligations	0	4M	0	36.9M	31.5M	30.2M	28.7M	95.5M
Deferred Tax Liabilities	0	25M	29.7M	46.1M	0	11.9M	62.6M	63.4M
Other Non-Current Liabilities	0	0	0	41.8M	57.2M	42.2M	0	168.7M
Total Liabilities	126M	166M	194M	1.98B	2.04B	2.02B	1.74B	1.66B
Total Debt	0	5M	0	1.64B	1.64B	1.61B	1.43B	1.36B
Net Debt	0	5M	0	1.31B	1.31B	1.34B	1.2B	1.17B
Debt / Equity	-	0.01x	-	-	-	-	-	-2.17x
Debt / EBITDA	-	0.01x	-	4.01x	6.25x	7.42x	3.76x	4.29x
Net Debt / EBITDA	-	0.01x	-	3.20x	5.00x	6.19x	3.17x	3.17x
Interest Coverage	-	-	-	6.55x	1.99x	1.39x	2.27x	39.48x
Total Equity	577M▲ 0%	572M▼ 0.9%	594M▲ 3.8%	-891.4M▼ 250.1%	-821.7M▲ 7.8%	-738.3M▲ 10.1%	-650.6M▲ 11.9%	-626.1M▲ 0%
Equity Growth %	-	-0.87%	3.85%	-250.07%	7.82%	10.15%	11.88%	59.41%
Book Value per Share	10.12	10.04	10.46	-15.62	-14.23	-12.66	-11.04	-10.63
Total Shareholders' Equity	577M	572M	594M	-891.4M	-821.7M	-738.3M	-650.6M	-626.1M
Common Stock	855M	834M	865M	600K	600K	600K	600K	600K
Retained Earnings	0	0	0	-577.1M	-541.1M	-498.6M	-445.6M	-424.7M
Treasury Stock	0	0	0	0	0	0	0	0
Accumulated OCI	-278M	-262M	-271M	-324.9M	-309.1M	-292.8M	-285.6M	-290M
Minority Interest	0	0	0	0	0	0	0	0

EMBC Cash Flow Statement

Embecta Corp. (EMBC) cash flow — operating, investing & free cash flow history

Line item	Sep'19	Sep'20	Sep'21	Sep'22	Sep'23	Sep'24	Sep'25	TTM
Cash from Operations	505M	498.5M	456M	412.2M	67.7M	35.7M	191.7M	191.7M
Operating CF Margin %	45.54%	45.92%	39.14%	36.49%	6.04%	3.18%	17.74%	-
Operating CF Growth %	-	-1.29%	-8.53%	-9.61%	-83.58%	-47.27%	436.97%	4506.98%
Net Income	432M	427.6M	415M	223.6M	70.4M	78.3M	95.4M	111.9M
Depreciation & Amortization	36M	38.3M	38M	31.7M	32.6M	36.2M	40.7M	37.8M
Stock-Based Compensation	12M	12.7M	12.8M	18.7M	21.5M	26.3M	31.6M	11.8M
Deferred Taxes	-6M	-2.2M	-2M	-26.5M	14.3M	-70.6M	17.6M	15.4M
Other Non-Cash Items	9M	9.4M	24.2M	72.3M	8.9M	13.2M	30.1M	1.2M
Working Capital Changes	22M	12.7M	-32M	92.4M	-80M	-47.7M	-23.7M	200K
Change in Receivables	-10M	-2.4M	-32M	122.7M	7M	-174.7M	44.2M	28.5M
Change in Inventory	9M	3.5M	-18M	-23.4M	-28.8M	-16.5M	-6.1M	-7.6M
Change in Payables	32M	-3.8M	30M	73.3M	7.9M	60M	-68.9M	-32.2M
Cash from Investing	-69M	-41.9M	-39M	-24M	-26.5M	-15.8M	-9.3M	1.8M
Capital Expenditures	-69M	-41.9M	-39M	-24M	-26.5M	-15.8M	-9.3M	-8.3M
CapEx % of Revenue	6.22%	3.86%	3.35%	2.12%	2.36%	1.41%	0.86%	-
Acquisitions	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	10.1M
Cash from Financing	-436M	-456.6M	-417M	-48M	-48.7M	-73.4M	-226.7M	-195.8M
Debt Issued (Net)	0	0	0	1.44B	-10.7M	-35.9M	-186M	-201.4M
Equity Issued (Net)	0	0	0	0	-3.6M	-3M	-5.7M	-200K
Dividends Paid	0	0	0	-8.6M	-34.4M	-34.5M	-35M	-35.3M
Share Repurchases	0	0	0	0	-3.6M	-3M	-5.7M	-200K
Other Financing	-436M	-456.6M	-417M	-1.48B	0	0	0	41.1M
Net Change in Cash	0▲ 0%	0▲ 0%	0▲ 0%	330.9M▲ 0%	-4.4M▼ 101.3%	-52.3M▼ 1088.6%	-45.6M▲ 12.8%	-18.9M▲ 0%
Free Cash Flow	436M▲ 0%	456.6M▲ 4.7%	417M▼ 8.7%	388.2M▼ 6.9%	41.2M▼ 89.4%	19.9M▼ 51.7%	182.4M▲ 816.6%	174.1M▲ 0%
FCF Margin %	39.31%	42.06%	35.79%	34.37%	3.68%	1.77%	16.88%	16.7%
FCF Growth %	-	4.72%	-8.67%	-6.91%	-89.39%	-51.7%	816.58%	338.54%
FCF per Share	7.65	8.01	7.34	6.80	0.71	0.34	3.10	3.10
FCF Conversion (FCF/Net Income)	1.17x	1.17x	1.10x	1.84x	0.96x	0.46x	2.01x	1.56x
Interest Paid	0	0	0	38.9M	111M	117.7M	103.8M	0
Taxes Paid	0	0	0	15.6M	30.4M	29.1M	50.1M	0

EMBC Key Ratios

Embecta Corp. (EMBC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	74.43%	71.15%	-	-	-	-	-17.49%
Return on Invested Capital (ROIC)	63.3%	63.02%	55.85%	37.76%	23.9%	42.7%	42.7%
Gross Margin	70.29%	68.67%	68.61%	66.91%	64.9%	62.89%	61.44%
Net Margin	39.39%	35.61%	19.8%	6.28%	6.97%	8.83%	10.73%
Debt / Equity	0.01x	-	-	-	-	-	-2.17x
Interest Coverage	-	-	6.55x	1.99x	1.39x	2.27x	39.48x
FCF Conversion	1.17x	1.10x	1.84x	0.96x	0.46x	2.01x	1.56x
Revenue Growth	-2.12%	7.32%	-3.05%	-0.77%	0.21%	-3.8%	-3.43%

EMBC SEC Filings & Documents

Embecta Corp. (EMBC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 5, 2026·SEC

Material company update

Mar 20, 2026·SEC

Material company update

Feb 13, 2026·SEC

10-K Annual Reports

FY 2025

Nov 25, 2025·SEC

FY 2024

Dec 11, 2024·SEC

FY 2023

Nov 29, 2023·SEC

10-Q Quarterly Reports

FY 2026

May 5, 2026·SEC

FY 2026

Feb 5, 2026·SEC

FY 2025

Aug 8, 2025·SEC

EMBC Frequently Asked Questions

Embecta Corp. (EMBC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Embecta Corp. (EMBC) reported $1.04B in revenue for fiscal year 2025. This represents a 6% decrease from $1.11B in 2019.

Embecta Corp. (EMBC) saw revenue decline by 3.8% over the past year.

Yes, Embecta Corp. (EMBC) is profitable, generating $111.9M in net income for fiscal year 2025 (8.8% net margin).

Dividend & Returns

Yes, Embecta Corp. (EMBC) pays a dividend with a yield of 16.69%. This makes it attractive for income-focused investors.

Embecta Corp. (EMBC) generated $174.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More EMBC

Embecta Corp. (EMBC) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Embecta Corp.(EMBC)Earnings, Financials & Key Ratios

EMBC Key Insights

✓Strengths

✗Weaknesses

EMBC Price & Volume

EMBC Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

EMBC Recent Earnings

EMBC Peer Comparison

Compare EMBC vs Peers

vs UTMD

vs LLY

Compare Top 5

EMBC Income Statement

EMBC Balance Sheet

EMBC Cash Flow Statement

EMBC Key Ratios

EMBC SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

EMBC Frequently Asked Questions

Explore More EMBC

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation